KPTI
Karyopharm Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.35
−11.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.02x
- Price / sales
- 0.05x
- Price / cash flow
- -0.12x
Enterprise value
- Enterprise value
- $158.6M
- EV / sales
- 1.08x
- EV / EBITDA
- -0.90x
- EV / EBIT
- -1.93x
- Market cap
- $7.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026